Indian FMCG major Emami Limited has announced its financial results for the second quarter of the fiscal year 2025, revealing a dip in both revenue and profit. Despite the challenging quarter, the company's board has approved a significant interim dividend for its shareholders.
Quarterly Financial Performance Overview
The Board of Directors of Emami Limited approved the unaudited financial results for the quarter and half-year ended September 30, 2025, in a meeting held on November 10, 2025. The company reported a consolidated revenue from operations of ₹798.51 crore for the July-September quarter. This marks a decrease of approximately 10% compared to the ₹890.59 crore it reported in the same period last year.
More notably, the company's bottom line saw a sharper contraction. The consolidated profit after tax (PAT) stood at ₹148.35 crore, reflecting a substantial decline of about 29.7% from the PAT of ₹210.99 crore recorded in Q2 of the previous fiscal year. This drop in profitability is attributed to various prevailing market factors. The earnings per share (EPS) for the quarter were reported at ₹3.40.
Domestic, International, and Standalone Results
A geographical breakdown shows that the company earned ₹618.32 crore from its operations within India, while revenue from international markets was ₹180.19 crore. This mix highlights Emami's strategic efforts to maintain a balanced presence in both domestic and global markets.
The company's standalone performance, which excludes the results of its subsidiaries, also mirrored the downward trend. Standalone revenue from operations was ₹604.47 crore, down about 14.7% from ₹709.01 crore in the corresponding quarter last year. Similarly, the standalone profit after tax decreased by 14.8% to ₹182.34 crore, compared to ₹214.10 crore a year ago.
Dividend Declaration Amidst Market Challenges
In a positive signal to its investors, the Emami board announced an interim dividend for the financial year 2024-25. The company declared a 400% interim dividend, which translates to ₹4 per equity share of ₹1 each. The record date to determine the eligibility of shareholders for this dividend payout has been fixed for November 14, 2025.
This move to reward shareholders comes even as the company navigates a period of financial pressure, demonstrating its commitment to returning value to its investors. The declaration of a substantial dividend provides a silver lining in an otherwise subdued quarterly report for the personal and healthcare giant.
